Analysen zu GSK PLC Registered Shs
| 07.01.26 | GSK Buy | Jefferies & Company Inc. | |
| 19.11.25 | GSK Buy | Jefferies & Company Inc. | |
| 05.11.25 | GSK Outperform | Bernstein Research | |
| 31.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 29.10.25 | GSK Outperform | Bernstein Research | |
| 29.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 27.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 06.08.25 | GSK Outperform | Bernstein Research | |
| 01.08.25 | GSK Outperform | Bernstein Research | |
| 28.07.25 | GSK Outperform | Bernstein Research | |
| 04.06.25 | GSK Outperform | Bernstein Research | |
| 16.05.25 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.25 | GSK Outperform | Bernstein Research | |
| 20.02.25 | GSK Outperform | Bernstein Research | |
| 07.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 07.01.25 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | GSK Outperform | Bernstein Research | |
| 02.12.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.24 | GSK Buy | Deutsche Bank AG | |
| 30.10.24 | GSK Outperform | Bernstein Research | |
| 11.10.24 | GSK Buy | Deutsche Bank AG | |
| 10.10.24 | GSK Buy | Deutsche Bank AG | |
| 09.10.24 | GSK Buy | Deutsche Bank AG | |
| 08.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 18.09.24 | GSK Buy | Jefferies & Company Inc. | |
| 09.09.24 | GSK Buy | Deutsche Bank AG | |
| 15.08.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.08.24 | GSK Buy | Deutsche Bank AG | |
| 31.07.24 | GSK Buy | Deutsche Bank AG | |
| 24.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 10.07.24 | GSK Buy | Deutsche Bank AG | |
| 04.07.24 | GSK Buy | Deutsche Bank AG | |
| 04.07.24 | GSK Buy | UBS AG | |
| 02.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 27.06.24 | GSK Buy | UBS AG | |
| 19.06.24 | GSK Buy | Deutsche Bank AG | |
| 18.06.24 | GSK Buy | UBS AG | |
| 17.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 04.06.24 | GSK Buy | UBS AG | |
| 04.06.24 | GSK Buy | Deutsche Bank AG | |
| 03.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.06.24 | GSK Buy | Deutsche Bank AG | |
| 13.05.24 | GSK Buy | Deutsche Bank AG | |
| 13.05.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.05.24 | GSK Outperform | Bernstein Research | |
| 06.05.24 | GSK Buy | UBS AG | |
| 02.05.24 | GSK Buy | Deutsche Bank AG | |
| 02.05.24 | GSK Buy | UBS AG |
Aktuelle Aktienanalysen
| 30.01.26 | ING Group Sector Perform | RBC Capital Markets | |
| 30.01.26 | Scout24 Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | SAFRAN Buy | Jefferies & Company Inc. | |
| 30.01.26 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 30.01.26 | MTU Aero Engines Buy | Jefferies & Company Inc. | |
| 30.01.26 | HENSOLDT Hold | Jefferies & Company Inc. | |
| 30.01.26 | RENK Buy | Jefferies & Company Inc. | |
| 30.01.26 | Rheinmetall Buy | Jefferies & Company Inc. | |
| 30.01.26 | Airbus Hold | Jefferies & Company Inc. | |
| 30.01.26 | Adyen B.V. Parts Sociales Buy | Jefferies & Company Inc. | |
| 30.01.26 | Deutsche Bank Overweight | Barclays Capital | |
| 30.01.26 | ING Group Kaufen | DZ BANK | |
| 30.01.26 | Tesla Buy | Deutsche Bank AG | |
| 30.01.26 | Tesla Equal Weight | Barclays Capital | |
| 30.01.26 | Apple Underweight | Barclays Capital | |
| 30.01.26 | adidas Kaufen | DZ BANK | |
| 30.01.26 | adidas Equal Weight | Barclays Capital | |
| 30.01.26 | SAP Overweight | Barclays Capital | |
| 30.01.26 | LVMH Moet Hennessy Louis Vuitton Equal Weight | Barclays Capital | |
| 30.01.26 | VINCI Overweight | Barclays Capital | |
| 30.01.26 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | DWS Group Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | Apple Hold | Jefferies & Company Inc. | |
| 30.01.26 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.26 | ABB Market-Perform | Bernstein Research | |
| 30.01.26 | Givaudan Neutral | UBS AG | |
| 30.01.26 | Roche Buy | UBS AG | |
| 30.01.26 | Nordea Bank Abp Registered Shs Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | Swiss Re Underweight | Barclays Capital | |
| 30.01.26 | Münchener Rückversicherungs-Gesellschaft Overweight | Barclays Capital | |
| 30.01.26 | Hannover Rück Underweight | Barclays Capital | |
| 30.01.26 | Assicurazioni Generali Underweight | Barclays Capital | |
| 30.01.26 | AXA Overweight | Barclays Capital | |
| 30.01.26 | Schaeffler Neutral | UBS AG | |
| 30.01.26 | Allianz Underweight | Barclays Capital | |
| 30.01.26 | Deutsche Bank Buy | UBS AG | |
| 30.01.26 | Roche Overweight | Barclays Capital | |
| 30.01.26 | Givaudan Overweight | Barclays Capital | |
| 30.01.26 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 30.01.26 | ING Group Buy | UBS AG | |
| 30.01.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 30.01.26 | HelloFresh Equal Weight | Barclays Capital | |
| 30.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | Givaudan Buy | Deutsche Bank AG | |
| 30.01.26 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 30.01.26 | Schaeffler Hold | Deutsche Bank AG | |
| 30.01.26 | Volvo AB Outperform | RBC Capital Markets | |
| 30.01.26 | Bilfinger Buy | Deutsche Bank AG | |
| 30.01.26 | Sanofi Buy | Deutsche Bank AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.